EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma

Sirjana Pun iD, Anusha Prakash, Dalee Demaree, Daniel Pomeranz Krummel iD, Giuseppe Sciumè, Soma Sengupta, Riccardo Barrile iD

Advanced Healthcare Materials · 2024-12 · 13 (30)

DOI: 10.1002/adhm.202401876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.08.2024. Verfasst von Sirjana Pun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, 45221, USA. Hauptthemen laut MEDLINE: Glioblastoma, Drug Resistance, Neoplasm, Temozolomide, Bioprinting. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Cincinnati, the Brain Tumor Center Research Award, University of Cincinnati, Neurobiology Research Center Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microphysiological systems (MPSs) reconstitute tissue interfaces and organ functions, presenting a promising alternative to animal models in drug development. However, traditional materials like polydimethylsiloxane (PDMS) often interfere by absorbing hydrophobic molecules, affecting drug testing accuracy. Additive manufacturing, including 3D bioprinting, offers viable solutions. GlioFlow3D, a novel microfluidic platform combining extrusion bioprinting and stereolithography (SLA) is introduced. GlioFlow3D integrates primary human cells and glioblastoma (GBM) lines in hydrogel‐based microchannels mimicking vasculature, within an SLA resin framework using cost‐effective materials. The study introduces a robust protocol to mitigate SLA resin cytotoxicity. Compared to PDMS, GlioFlow3D demonstrated lower small molecule absorption, which is relevant for accurate testing of small molecules like Temozolomide (TMZ). Computational modeling is used to optimize a pumpless setup simulating interstitial fluid flow dynamics in tissues. Co‐culturing GBM with brain endothelial cells in GlioFlow3D showed enhanced CD133 expression and TMZ resistance near vascular interfaces, highlighting spatial drug resistance mechanisms. This PDMS‐free platform promises advanced drug testing, improving preclinical research and personalized therapy by elucidating complex GBM drug resistance mechanisms influenced by the tissue microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaDrug Resistance, NeoplasmTemozolomideBioprintingHumansCell Line, TumorHydrogelsBrain NeoplasmsLab-On-A-Chip DevicesPrinting, Three-DimensionalCoculture TechniquesStereolithographyDimethylpolysiloxanesMicrophysiological Systems

Stichwörter der Autor:innen

3D printingbioprintingglioblastomamicrophysiological systemsorgan‐on‐Chiprapid prototyping

Substanzen

TemozolomideHydrogelsDimethylpolysiloxanes

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, 45221, USA.
  • Abbvie, Worcester, Massachusetts, 01605, USA.
  • Thermo Fisher Scientific, Waltham, Massachusetts, 02451, USA.
  • Department of Neurology, University of Cincinnati, Cincinnati, OH, 45219, USA.
  • Department of Neurosurgery, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Institute of Mechanics and Engineering-12 M, University of Bordeaux, Bordeaux, 33607, France.

ORCID-Profile: Sirjana Pun, Daniel Pomeranz Krummel, Riccardo Barrile

Förderung

  • University of Cincinnati, the Brain Tumor Center Research Award
  • University of Cincinnati, Neurobiology Research Center Research Award

Zitieren

APA

Pun, S., Prakash, A., Demaree, D., Krummel, D. P., Sciumè, G., Sengupta, S., & Barrile, R. (2024). Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Advanced Healthcare Materials, 13(30). https://doi.org/10.1002/adhm.202401876

Vancouver

Pun S, Prakash A, Demaree D, Krummel DP, Sciumè G, Sengupta S, et al. Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Advanced Healthcare Materials. 2024;13(30). doi:10.1002/adhm.202401876

BibTeX
@article{Pun2024,
  author = {Pun, Sirjana and Prakash, Anusha and Demaree, Dalee and Krummel, Daniel Pomeranz and Sciumè, Giuseppe and Sengupta, Soma and Barrile, Riccardo},
  title = {Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {30},
  doi = {10.1002/adhm.202401876}
}
Kostenlos starten →